Coronavirus • 22 April, 2020

Germany approves first human trials for vaccine

3 time viewed

A clinical test of a Covid-19 vaccine has been approved in Germany, the country’s Federal Institute for Vaccines has said.

In the first part of the trial, 200 healthy people between 18 and 55 will receive several variants of the vaccine.

The vaccine candidate was produced by biotech firm BioNTech, and is an RNA vaccine.

There are 86 teams across the world currently working to develop a Covid-19 vaccine, including a handful at the clinical trial stage.

Germany follows the UK in approving a human trial after health secretary Matt Hancock announced scientists at Oxford University will begin testing a vaccine on people this Thursday. 

Around 500 volunteers are expected to enrol in the programme by mid-May, with the British government pledging £20m to the research.

In China, early-stage human tests for two experimental vaccines were approved earlier this month, according to state media Xinhua.


Last news

2.6 million students to study in distance

Education • 06 August, 2020

375 people died from coronavirus infection

Coronavirus • 13 July, 2020

Turkey sends humanitarian aid to Kazakhstan

Coronavirus • 13 July, 2020

Kazakhstan mourns Covid-19 victims today

Kazakhstan • 13 July, 2020

How the main city of Kazakhstan developed

Kazakhstan • 08 July, 2020

Russian doctors arrive in Kazakhstan

Coronavirus • 07 July, 2020

Nursultan Nazarbayev marks his 80th birthday

Елбасы • 07 July, 2020

Similar news